Use of Somatropin in Japanese Patients with Prader-Willi Syndrome (PWS)
A Phase 3 Multicenter, Open Label, Multi Cohort Study to Evaluate the Efficacy and Safety of Somatropin in Japanese Participants With Prader-Willi Syndrome (PWS)
Category & Conditions: Rare Diseases
Medicine: GENOTROPIN(SOMATROPIN [RDNA ORIGIN])
ClinicalTrials.gov Identifier (NCT): NCT04697381
Protocol ID: A6281323
PrintDownloadOpen Plain Language Summary Result: Click here